Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003615

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • CCOP - Southern Nevada Cancer Research Foundation Las Vegas, Nevada, United States
  • Trinitas Hospital - Jersey Street Campus Elizabeth, New Jersey, United States
View Trial Details
Completed

A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT00481091

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 5566 La Jolla, California, United States
  • Dana-Farber Cancer Institute /ID# 5547 Boston, Massachusetts, United States
  • University of Nebraska Medical Center /ID# 12261 Omaha, Nebraska, United States
  • North Shore University Hospital /ID# 12267 New Hyde Park, New York, United States
View Trial Details
Completed

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

NCT01682616

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 70398 La Jolla, California, United States
  • Northwestern University Feinberg School of Medicine /ID# 71593 Chicago, Illinois, United States
  • North Shore University Hospital /ID# 71813 New Hyde Park, New York, United States
  • Duke Cancer Center /ID# 71393 Durham, North Carolina, United States
View Trial Details
Completed

Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19

NCT04391946

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease, Disease Attributes, +14 more
Locations
  • Chu Angers Angers, France
  • CHU Jean Minjoz - Hématologie Besançon, France
  • Hôpital Avicenne - Centre de Recherche Clinique Bobigny, France
  • CHU Estaing - Hématologie Clinique Adulte Clermont-Ferrand, France
View all 22 locations
View Trial Details
Completed

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

NCT00602459

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • PCR Oncology Arroyo Grande, California, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Palo Alto Medical Foundation-Camino Division Mountain View, California, United States
View all 364 locations
View Trial Details
Completed

Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01027000

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando, Florida, United States
View all 25 locations
View Trial Details

Related conditions